Global CSR Program | Takeda Pharmaceuticals
Global CSR Program
Transforming health outcomes by investing in resilient health systems worldwide
Takeda’s Global Corporate Social Responsibility (CSR) Program is a signature initiative of our philanthropic giving, which supports solutions that strengthen the resiliency of health systems in low and middle-income countries (LMICs). This program is unique in that we empower our 50,000 employees around the globe to participate in the selection of new partners each year through a worldwide vote. The vote ensures that our community of long-term partnerships reflects the priorities and preferences of all our colleagues.
Our giving is focused on addressing the impacts of climate change on health through three key pillars: reliable health infrastructure, climate-smart workforce education, and technology innovation and solutions to enhance diagnosis and treatment for climate-vulnerable populations. See below for information about our partners.
To learn more about our broader philanthropic giving approach, please visit our CSR Partnerships page.
FY2023 Programs
The newest Global CSR Program awardees were announced at a web event. The theme for the program was "Empowering Action: Catalyzing sustainable and equitable health systems."
It began with a welcome message from our Chief Global Corporate Affairs & Sustainability Officer, followed by a fireside chat with panelists Mia Malan, Founding Editor-in-Chief of Bhekisisa and Janet Muriuki, Senior Director of Health Workforce Development (interim) & Kenya Country Director at IntraHealth International, moderated by Anu Kumar, CEO of Ipas.
Watch the Global CSR Program 2023 web event here.